{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:26:11Z","timestamp":1786987571471,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"HHS | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R43NS112050"],"award-info":[{"award-number":["R43NS112050"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"HHS | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R44NS130776-01"],"award-info":[{"award-number":["R44NS130776-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000076","name":"NSF | Directorate for Biological Sciences","doi-asserted-by":"publisher","award":["1548490"],"award-info":[{"award-number":["1548490"]}],"id":[{"id":"10.13039\/100000076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000076","name":"NSF | Directorate for Biological Sciences","doi-asserted-by":"publisher","award":["1660165"],"award-info":[{"award-number":["1660165"]}],"id":[{"id":"10.13039\/100000076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2025,11,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Traumatic brain injury (TBI) is a major clinical problem because of the high incidence and the severity of the subsequent sequelae. Despite extensive efforts, there are no therapeutic drugs clinically approved for treating acute TBI patients. To address this unmet need, we assessed the activity of the tetrapeptide, CAQK, in mice. When administered intravenously shortly after moderate or severe TBI, CAQK accumulates in the injured brain in mice and pigs. CAQK binds to an extracellular matrix glycoprotein complex that is upregulated in injured brain. Treatment of TBI mice with CAQK resulted in reduction in the size of the injury compared to control mice. There was reduced upregulation of the glycoprotein complex, less apoptosis, and lower expression of inflammatory markers in the injured area, indicating that CAQK alleviates neuroinflammation and the ensuing secondary injury. CAQK treatment also improved functional deficit in TBI mice, with no overt toxicity. Our findings suggest that CAQK may have therapeutic applications in TBI.<\/jats:p>","DOI":"10.1038\/s44321-025-00312-5","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:53:00Z","timestamp":1759315980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A neuroprotective tetrapeptide for treatment of acute traumatic brain injury"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8156-7473","authenticated-orcid":false,"given":"Aman P","family":"Mann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sazid","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0745-2467","authenticated-orcid":false,"given":"Pablo","family":"Scodeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope N B","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elan","family":"Sherazee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6588-1249","authenticated-orcid":false,"given":"Erkki","family":"Ruoslahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"312_CR1","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.908401","volume":"16","author":"C Abi-Ghanem","year":"2022","unstructured":"Abi-Ghanem C, Jonnalagadda D, Chun J, Kihara Y, Ranscht B (2022) CAQK, a peptide associating with extracellular matrix components targets sites of demyelinating injuries. Front Cell Neurosci 16:908401","journal-title":"Front Cell Neurosci"},{"key":"312_CR2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3171\/jns.1996.85.6.1113","volume":"85","author":"P Barzo","year":"1996","unstructured":"Barzo P, Marmarou A, Fatouros P, Corwin F, Dunbar J (1996) Magnetic resonance imaging-monitored acute blood-brain barrier changes in experimental traumatic brain injury. J Neurosurg 85:1113\u20131121","journal-title":"J Neurosurg"},{"key":"312_CR3","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3390\/cells11111773","volume":"11","author":"J Bauch","year":"2022","unstructured":"Bauch J, Faissner A (2022) The extracellular matrix proteins tenascin-C and tenascin-R retard oligodendrocyte precursor maturation and myelin regeneration in a cuprizone-induced long-term demyelination animal model. Cells 11:1773","journal-title":"Cells"},{"key":"312_CR4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","volume":"80","author":"N Carney","year":"2017","unstructured":"Carney N, Totten AM, O\u2019Reilly C, Ullman JS, Hawryluk GW, Bell MJ, Bratton SL, Chesnut R, Harris OA, Kissoon N et al. (2017) Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery 80:6\u201315","journal-title":"Neurosurgery"},{"key":"312_CR5","doi-asserted-by":"crossref","unstructured":"Carter RJ, Morton J, Dunnett SB (2001) Motor coordination and balance in rodents. Curr Protoc Neurosci Chapter 8: Unit 8 12","DOI":"10.1002\/0471142301.ns0812s15"},{"key":"312_CR6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00381-009-1029-x","volume":"26","author":"D Cederberg","year":"2010","unstructured":"Cederberg D, Siesjo P (2010) What has inflammation to do with traumatic brain injury? Childs Nerv Syst 26:221\u2013226","journal-title":"Childs Nerv Syst"},{"key":"312_CR7","doi-asserted-by":"crossref","unstructured":"Crawley J (2007) What\u2019s wrong with my mouse? Behavioral phenotyping of transgenic and knockout mice. Wiley-Interscience","DOI":"10.1002\/0470119055"},{"key":"312_CR8","doi-asserted-by":"crossref","first-page":"12310","DOI":"10.1523\/JNEUROSCI.4957-09.2010","volume":"30","author":"T Czopka","year":"2010","unstructured":"Czopka T, von Holst A, ffrench-Constant C, Faissner A (2010) Regulatory mechanisms that mediate tenascin C-dependent inhibition of oligodendrocyte precursor differentiation. J Neurosci 30:12310\u201312322","journal-title":"J Neurosci"},{"key":"312_CR9","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/glia.20891","volume":"57","author":"T Czopka","year":"2009","unstructured":"Czopka T, Von Holst A, Schmidt G, Ffrench-Constant C, Faissner A (2009) Tenascin C and tenascin R similarly prevent the formation of myelin membranes in a RhoA-dependent manner, but antagonistically regulate the expression of myelin basic protein via a separate pathway. Glia 57:1790\u20131801","journal-title":"Glia"},{"key":"312_CR10","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","volume":"130","author":"MC Dewan","year":"2019","unstructured":"Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M, Agrawal A, Adeleye AO, Shrime MG, Rubiano AM et al. (2019) Estimating the global incidence of traumatic brain injury. J Neurosurg 130:1080\u20131097","journal-title":"J Neurosurg"},{"key":"312_CR11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/antiox9030260","volume":"9","author":"V Di Pietro","year":"2020","unstructured":"Di Pietro V, Yakoub KM, Caruso G, Lazzarino G, Signoretti S, Barbey AK, Tavazzi B, Lazzarino G, Belli A, Amorini AM (2020) Antioxidant therapies in traumatic brain injury. Antioxidants 9:260","journal-title":"Antioxidants"},{"key":"312_CR12","doi-asserted-by":"crossref","first-page":"e90617","DOI":"10.1371\/journal.pone.0090617","volume":"9","author":"K Eakin","year":"2014","unstructured":"Eakin K, Baratz-Goldstein R, Pick CG, Zindel O, Balaban CD, Hoffer ME, Lockwood M, Miller J, Hoffer BJ (2014) Efficacy of N-acetyl cysteine in traumatic brain injury. PLoS One 9:e90617","journal-title":"PLoS One"},{"key":"312_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0166-4328(03)00109-8","volume":"145","author":"S Freitag","year":"2003","unstructured":"Freitag S, Schachner M, Morellini F (2003) Behavioral alterations in mice deficient for the extracellular matrix glycoprotein tenascin-R. Behav Brain Res 145:189\u2013207","journal-title":"Behav Brain Res"},{"key":"312_CR14","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1111\/j.1460-9568.2004.03727.x","volume":"20","author":"J Garwood","year":"2004","unstructured":"Garwood J, Garcion E, Dobbertin A, Heck N, Calco V, ffrench-Constant C, Faissner A (2004) The extracellular matrix glycoprotein Tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor. Eur J Neurosci 20:2524\u20132540","journal-title":"Eur J Neurosci"},{"key":"312_CR15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.forsciint.2004.06.027","volume":"146","author":"SM Gentleman","year":"2004","unstructured":"Gentleman SM, Leclercq PD, Moyes L, Graham DI, Smith C, Griffin WS, Nicoll JA (2004) Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int 146:97\u2013104","journal-title":"Forensic Sci Int"},{"key":"312_CR16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jnr.24151","volume":"96","author":"N George","year":"2018","unstructured":"George N, Geller HM (2018) Extracellular matrix and traumatic brain injury. J Neurosci Res 96:573\u2013588","journal-title":"J Neurosci Res"},{"key":"312_CR17","first-page":"1147","volume":"74","author":"JR Hay","year":"2015","unstructured":"Hay JR, Johnson VE, Young AM, Smith DH, Stewart W (2015) Blood-brain barrier disruption is an early event that may persist for many years after traumatic brain injury in humans. J Neuropathol Exp Neurol 74:1147\u20131157","journal-title":"J Neuropathol Exp Neurol"},{"key":"312_CR18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMct0708278","volume":"359","author":"KJ Heard","year":"2008","unstructured":"Heard KJ (2008) Acetylcysteine for acetaminophen poisoning. N Engl J Med 359:285\u2013292","journal-title":"N Engl J Med"},{"key":"312_CR19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-88693-8","volume":"11","author":"N Hegdekar","year":"2021","unstructured":"Hegdekar N, Lipinski MM, Sarkar C (2021) N-acetyl-L-leucine improves functional recovery and attenuates cortical cell death and neuroinflammation after traumatic brain injury in mice. Sci Rep 11:9249","journal-title":"Sci Rep"},{"key":"312_CR20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/brain\/aws322","volume":"136","author":"VE Johnson","year":"2013","unstructured":"Johnson VE, Stewart JE, Begbie FD, Trojanowski JQ, Smith DH, Stewart W (2013) Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain 136:28\u201342","journal-title":"Brain"},{"key":"312_CR21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archpsyc.61.1.42","volume":"61","author":"RE Jorge","year":"2004","unstructured":"Jorge RE, Robinson RG, Moser D, Tateno A, Crespo-Facorro B, Arndt S (2004) Major depression following traumatic brain injury. Arch Gen Psychiatry 61:42\u201350","journal-title":"Arch Gen Psychiatry"},{"key":"312_CR22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2174\/1871527317666180627120501","volume":"17","author":"N Khatri","year":"2018","unstructured":"Khatri N, Thakur M, Pareek V, Kumar S, Sharma S, Datusalia AK (2018) Oxidative stress: major threat in traumatic brain injury. CNS Neurol Disord Drug Targets 17:689\u2013695","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"312_CR23","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.4049\/jimmunol.166.7.4634","volume":"166","author":"T Kielian","year":"2001","unstructured":"Kielian T, Barry B, Hickey WF (2001) CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J Immunol 166:4634\u20134643","journal-title":"J Immunol"},{"key":"312_CR24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1006\/mcne.1996.0024","volume":"7","author":"BW Kiernan","year":"1996","unstructured":"Kiernan BW, Gotz B, Faissner A, ffrench-Constant C (1996) Tenascin-C inhibits oligodendrocyte precursor cell migration by both adhesion-dependent and adhesion-independent mechanisms. Mol Cell Neurosci 7:322\u2013335","journal-title":"Mol Cell Neurosci"},{"key":"312_CR25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/02699052.2018.1438665","volume":"32","author":"CH Koh","year":"2018","unstructured":"Koh CH, Pronin S, Hughes M (2018) Chondroitinase ABC for neurological recovery after acute brain injury: systematic review and meta-analyses of preclinical studies. Brain Inj 32:715\u2013729","journal-title":"Brain Inj"},{"key":"312_CR26","doi-asserted-by":"crossref","unstructured":"Korley FK, Yue JK, Wilson DH, Hrusovsky K, Diaz-Arrastia R, Ferguson AR, Yuh EL, Mukherjee P, Wang KKW, Valadka AB et al (2018) Performance evaluation of a multiplex assay for simultaneous detection of four clinically relevant traumatic brain injury biomarkers. J Neurotrauma 36:182\u2013187","DOI":"10.1089\/neu.2017.5623"},{"key":"312_CR27","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4103\/1673-5374.257520","volume":"14","author":"L Koza","year":"2019","unstructured":"Koza L, Linseman DA (2019) Glutathione precursors shield the brain from trauma. Neural Regen Res 14:1701\u20131702","journal-title":"Neural Regen Res"},{"key":"312_CR28","doi-asserted-by":"crossref","first-page":"e24341","DOI":"10.1371\/journal.pone.0024341","volume":"6","author":"M Krajewska","year":"2011","unstructured":"Krajewska M, You Z, Rong J, Kress C, Huang X, Yang J, Kyoda T, Leyva R, Banares S, Hu Y et al (2011) Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity. PLoS ONE 6:e24341","journal-title":"PLoS ONE"},{"key":"312_CR29","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1073\/pnas.89.7.2634","volume":"89","author":"ED Laywell","year":"1992","unstructured":"Laywell ED, Dorries U, Bartsch U, Faissner A, Schachner M, Steindler DA (1992) Enhanced expression of the developmentally regulated extracellular matrix molecule tenascin following adult brain injury. Proc Natl Acad Sci USA 89:2634\u20132638","journal-title":"Proc Natl Acad Sci USA"},{"key":"312_CR30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1517\/17460441.2011.537322","volume":"6","author":"WA Lea","year":"2011","unstructured":"Lea WA, Simeonov A (2011) Fluorescence polarization assays in small molecule screening. Expert Opin Drug Discov 6:17\u201332","journal-title":"Expert Opin Drug Discov"},{"key":"312_CR31","volume":"41","author":"T Li","year":"2022","unstructured":"Li T, Jing P, Yang L, Wan Y, Du X, Wei J, Zhou M, Liu Z, Lin Y, Zhong Z (2022) CAQK modification enhances the targeted accumulation of metformin-loaded nanoparticles in rats with spinal cord injury. Nanomedicine 41:102526","journal-title":"Nanomedicine"},{"key":"312_CR32","volume":"216","author":"LLN Lucena","year":"2022","unstructured":"Lucena LLN, Briones MVA (2022) Effect of cerebrolysin in severe traumatic brain injury: a multi-center, retrospective cohort study. Clin Neurol Neurosurg 216:107216","journal-title":"Clin Neurol Neurosurg"},{"key":"312_CR33","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.str.2004.05.021","volume":"12","author":"A Lundell","year":"2004","unstructured":"Lundell A, Olin AI, Morgelin M, al-Karadaghi S, Aspberg A, Logan DT (2004) Structural basis for interactions between tenascins and lectican C-type lectin domains: evidence for a crosslinking role for tenascins. Structure 12:1495\u20131506","journal-title":"Structure"},{"key":"312_CR34","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43848-1","volume":"14","author":"H Maldonado","year":"2023","unstructured":"Maldonado H, Savage BD, Barker HR, May U, Vahatupa M, Badiani RK, Wolanska KI, Turner CMJ, Pemmari T, Ketomaki T et al (2023) Systemically administered wound-homing peptide accelerates wound healing by modulating syndecan-4 function. Nat Commun 14:8069","journal-title":"Nat Commun"},{"key":"312_CR35","volume":"7","author":"AP Mann","year":"2016","unstructured":"Mann AP, Scodeller P, Hussain S, Joo J, Kwon E, Braun GB, Molder T, She ZG, Kotamraju VR, Ranscht B et al (2016) A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries. Nat Commun 7:11980","journal-title":"Nat Commun"},{"key":"312_CR36","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1515\/cclm-2019-0034","volume":"57","author":"K Minta","year":"2019","unstructured":"Minta K, Cullen NC, Nimer FA, Thelin EP, Piehl F, Clarin M, Tullberg M, Jeppsson A, Portelius E, Zetterberg H et al (2019) Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury. Clin Chem Lab Med 57:1565\u20131573","journal-title":"Clin Chem Lab Med"},{"key":"312_CR37","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1089\/neu.2007.0377","volume":"24","author":"K Nagamoto-Combs","year":"2007","unstructured":"Nagamoto-Combs K, McNeal DW, Morecraft RJ, Combs CK (2007) Prolonged microgliosis in the rhesus monkey central nervous system after traumatic brain injury. J Neurotrauma 24:1719\u20131742","journal-title":"J Neurotrauma"},{"key":"312_CR38","first-page":"528","volume":"13","author":"SY Ng","year":"2019","unstructured":"Ng SY, Lee AYW (2019) Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci 13:528","journal-title":"Front Cell Neurosci"},{"key":"312_CR39","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/neu.1999.16.1023","volume":"16","author":"M Nonaka","year":"1999","unstructured":"Nonaka M, Chen XH, Pierce JE, Leoni MJ, McIntosh TK, Wolf JA, Smith DH (1999) Prolonged activation of NF-kappaB following traumatic brain injury in rats. J Neurotrauma 16:1023\u20131034","journal-title":"J Neurotrauma"},{"key":"312_CR40","volume":"11","author":"T Okada","year":"2020","unstructured":"Okada T, Suzuki H (2020) The role of tenascin-C in tissue injury and repair after stroke. Front Immunol 11:607587","journal-title":"Front Immunol"},{"key":"312_CR41","volume":"5","author":"HB Pang","year":"2014","unstructured":"Pang HB, Braun GB, Friman T, Aza-Blanc P, Ruidiaz ME, Sugahara KN, Teesalu T, Ruoslahti E (2014) An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability. Nat Commun 5:4904","journal-title":"Nat Commun"},{"key":"312_CR42","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ana.22455","volume":"70","author":"AF Ramlackhansingh","year":"2011","unstructured":"Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, Gentleman S, Heckemann RA, Gunanayagam K, Gelosa G et al (2011) Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol 70:374\u2013383","journal-title":"Ann Neurol"},{"key":"312_CR43","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2174\/1570159X16666180911121847","volume":"17","author":"A Rana","year":"2019","unstructured":"Rana A, Singh S, Sharma R, Kumar A (2019) Traumatic brain injury altered normal brain signaling pathways: implications for novel therapeutics approaches. Curr Neuropharmacol 17:614\u2013629","journal-title":"Curr Neuropharmacol"},{"key":"312_CR44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/glycob\/6.5.489","volume":"6","author":"E Ruoslahti","year":"1996","unstructured":"Ruoslahti E (1996) Brain extracellular matrix. Glycobiology 6:489\u2013492","journal-title":"Glycobiology"},{"key":"312_CR45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2016.03.008","volume":"110-111","author":"E Ruoslahti","year":"2017","unstructured":"Ruoslahti E (2017) Tumor penetrating peptides for improved drug delivery. Adv Drug Deliv Rev 110-111:3\u201312","journal-title":"Adv Drug Deliv Rev"},{"key":"312_CR46","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1023\/A:1012117815460","volume":"14","author":"T Sakane","year":"1997","unstructured":"Sakane T, Pardridge WM (1997) Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity. Pharm Res 14:1085\u20131091","journal-title":"Pharm Res"},{"key":"312_CR47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2016.07.020","volume":"238","author":"ZG She","year":"2016","unstructured":"She ZG, Hamzah J, Kotamraju VR, Pang HB, Jansen S, Ruoslahti E (2016) Plaque-penetrating peptide inhibits development of hypoxic atherosclerotic plaque. J Control Release 238:212\u2013220","journal-title":"J Control Release"},{"key":"312_CR48","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12975-014-0333-2","volume":"5","author":"M Shiba","year":"2014","unstructured":"Shiba M, Fujimoto M, Imanaka-Yoshida K, Yoshida T, Taki W, Suzuki H (2014) Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats. Transl Stroke Res 5:238\u2013247","journal-title":"Transl Stroke Res"},{"key":"312_CR49","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/089771501316919139","volume":"18","author":"PF Stahel","year":"2001","unstructured":"Stahel PF, Morganti-Kossmann MC, Perez D, Redaelli C, Gloor B, Trentz O, Kossmann T (2001) Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury. J Neurotrauma 18:773\u2013781","journal-title":"J Neurotrauma"},{"key":"312_CR50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/1535-7163.MCT-14-0366","volume":"14","author":"KN Sugahara","year":"2015","unstructured":"Sugahara KN, Braun GB, de Mendoza TH, Kotamraju VR, French RP, Lowy AM, Teesalu T, Ruoslahti E (2015) Tumor-penetrating iRGD peptide inhibits metastasis. Mol Cancer Ther 14:120\u2013128","journal-title":"Mol Cancer Ther"},{"key":"312_CR51","doi-asserted-by":"crossref","first-page":"16157","DOI":"10.1073\/pnas.0908201106","volume":"106","author":"T Teesalu","year":"2009","unstructured":"Teesalu T, Sugahara KN, Kotamraju VR, Ruoslahti E (2009) C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci USA 106:16157\u201316162","journal-title":"Proc Natl Acad Sci USA"},{"key":"312_CR52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnana.2013.00003","volume":"7","author":"L Ventura-Antunes","year":"2013","unstructured":"Ventura-Antunes L, Mota B, Herculano-Houzel S (2013) Different scaling of white matter volume, cortical connectivity, and gyrification across rodent and primate brains. Front Neuroanat 7:3","journal-title":"Front Neuroanat"},{"key":"312_CR53","volume":"133","author":"B Wang","year":"2022","unstructured":"Wang B, Chang M, Zhang R, Wo J, Wu B, Zhang H, Zhou Z, Li Z, Zhang F, Zhong C et al (2022) Spinal cord injury target-immunotherapy with TNF-alpha autoregulated and feedback-controlled human umbilical cord mesenchymal stem cell derived exosomes remodelled by CRISPR\/Cas9 plasmid. Biomater Adv 133:112624","journal-title":"Biomater Adv"},{"key":"312_CR54","volume":"16","author":"J Wang","year":"2020","unstructured":"Wang J, Li D, Liang C, Wang C, Zhou X, Ying L, Tao Y, Xu H, Shu J, Huang X et al (2020) Scar tissue-targeting polymer micelle for spinal cord injury treatment. Small 16:e1906415","journal-title":"Small"},{"key":"312_CR55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/14737159.2018.1428089","volume":"18","author":"KK Wang","year":"2018","unstructured":"Wang KK, Yang Z, Zhu T, Shi Y, Rubenstein R, Tyndall JA, Manley GT (2018a) An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn 18:165\u2013180","journal-title":"Expert Rev Mol Diagn"},{"key":"312_CR56","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.7150\/thno.26717","volume":"8","author":"Q Wang","year":"2018","unstructured":"Wang Q, Zhang H, Xu H, Zhao Y, Li Z, Li J, Wang H, Zhuge D, Guo X, Xu H et al (2018b) Novel multi-drug delivery hydrogel using scar-homing liposomes improves spinal cord injury repair. Theranostics 8:4429\u20134446","journal-title":"Theranostics"},{"key":"312_CR57","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0014-5793(96)00609-6","volume":"389","author":"P Weber","year":"1996","unstructured":"Weber P, Ferber P, Fischer R, Winterhalter KH, Vaughan L (1996) Binding of contactin\/F11 to the fibronectin type III domains 5 and 6 of tenascin is inhibited by heparin. FEBS Lett 389:304\u2013308","journal-title":"FEBS Lett"},{"key":"312_CR58","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1523\/JNEUROSCI.1346-04.2004","volume":"24","author":"BD Winters","year":"2004","unstructured":"Winters BD, Forwood SE, Cowell RA, Saksida LM, Bussey TJ (2004) Double dissociation between the effects of peri-postrhinal cortex and hippocampal lesions on tests of object recognition and spatial memory: heterogeneity of function within the temporal lobe. J Neurosci 24:5901\u20135908","journal-title":"J Neurosci"},{"key":"312_CR59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski JR, Zougman A, Nagaraj N, Mann M (2009) Universal sample preparation method for proteome analysis. Nat Methods 6:359\u2013362","journal-title":"Nat Methods"},{"key":"312_CR60","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.2147\/IJN.S202353","volume":"14","author":"P Wu","year":"2019","unstructured":"Wu P, Zhao H, Gou X, Wu X, Zhang S, Deng G, Chen Q (2019) Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury. Int J Nanomedicine 14:4059\u20134069","journal-title":"Int J Nanomedicine"},{"key":"312_CR61","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2017.07.018","volume":"472","author":"YY Zhao","year":"2017","unstructured":"Zhao YY, Lou L, Yang KC, Wang HB, Xu Y, Lu G, He HY (2017) Correlation of tenascin-C concentrations in serum with outcome of traumatic brain injury in humans. Clin Chim Acta 472:46\u201350","journal-title":"Clin Chim Acta"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00312-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:28:32Z","timestamp":1786984112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00312-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":61,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,10]]}},"alternative-id":["312"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00312-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.04.17.649010","asserted-by":"object"}]},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"11 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"APM, SH, PS, and ER are inventors on the patents. APM, SH and ER have ownership interest in AivoCode and are founders and officers of the company. The remaining authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"9"}}